New insights into the natural history of hepatitis E virus infection through a longitudinal study of multitransfused immunocompetent patients in France

Journal of Viral Hepatitis

Volumn 23, Issue 7, 2016, Pages 569-575

  Servant Delmas, A ^a   Abravanel, F ^b,c   Lefrere J J ^a,d   Lionnet, F ^e   Hamon, C ^a   Izopet, J ^b,c   Laperche, S ^a  

^a INSTITUT NATIONAL DE LA TRANSFUSION SANGUINE   (France)

^b UNIVERSITÉ PAUL SABATIER   (France)

^c University of Toulouse III   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e HÔPITAL TENON   (France)

Author keywords

blood transmission; hepatitis E virus; reinfection; seroreversion

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; VIRUS RNA;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CHILD; FEMALE; FOLLOW UP; FRANCE; HEMOGLOBINOPATHY; HEPATITIS E; HUMAN; IMMUNOCOMPETENCE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; REINFECTION; SEROCONVERSION; VIRUS TRANSMISSION; WESTERN EUROPE;

EID: 84975138854     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/jvh.12531     Document Type: Article

References (45)

1. Balayan MS, Andjaparidze AG, Savinskaya SS et al. Evidence for a virus in non-A, non-B hepatitis transmitted via the fecal-oral route. Intervirology 1983; 20: 23–31.
2. Reyes GR, Purdy MA, Kim JP et al. Isolation of a cDNA from the virus responsible for enterically transmitted non-A, non-B hepatitis. Science 1990; 247: 1335–1339.
3. Kamar N, Dalton HR, Abravanel F, Izopet J. Hepatitis E virus infection. Clin Microbiol Rev 2014; 27: 116–138.
4. Abravanel F, Chapuy-Regaud S, Lhomme S et al. Performance of anti-HEV assays for diagnosing acute hepatitis E in immunocompromised patients. J Clin Virol 2013; 58: 624–628.
5. Beale MA, Tettmar K, Szypulska R, Tedder RS, Ijaz S. Is there evidence of recent hepatitis E virus infection in English and North Welsh blood donors? Vox Sang 2011; 100: 340–342.
6. Cleland A, Smith L, Crossan C et al. Hepatitis E virus in Scottish blood donors. Vox Sang 2013; 105: 283–289.
7. Xu C, Wang RY, Schechterly CA et al. An assessment of hepatitis E virus (HEV) in US blood donors and recipients: no detectable HEV RNA in 1939 donors tested and no evidence for HEV transmission to 362 prospectively followed recipients. Transfusion 2013; 53: 2505–2511.
8. Sauleda S, Ong E, Bes M et al. Seroprevalence of hepatitis E virus (HEV) and detection of HEV RNA with a transcription-mediated amplification assay in blood donors from Catalonia (Spain). Transfusion 2015; 55: 972–979.
9. Gallian P, Piquet Y, Assal A et al. Hepatitis E virus: blood transfusion implications. Transfus Clin Biol 2014; 21: 173–177.
10. Slot E, Hogema BM, Riezebos-Brilman A, Kok TM, Molier M, Zaaijer HL. Silent hepatitis E virus infection in Dutch blood donors, 2011 to 2012. Euro Surveill 2013; 18(31): ppi=20550.
11. Guo QS, Yan Q, Xiong JH et al. Prevalence of hepatitis E virus in Chinese blood donors. J Clin Microbio 2010; 48: 317–318.
12. Hogema BM, Molier M, Slot E, Zaaijer HL. Past and present of hepatitis E in the Netherlands. Transfusion 2014; 54: 3092–3096.
13. Ijaz S, Said B, Boxall E, Smit E, Morgan D, Tedder RS. Indigenous hepatitis E in England and wales from 2003 to 2012: evidence of an emerging novel phylotype of viruses. J Infect Dis 2014; 209: 1212–1218.
14. Koot H, Hogema BM, Koot M, Molier M, Zaaijer HL. Frequent hepatitis E in the Netherlands without traveling or immunosuppression. J Clin Virol 2015; 62: 38–40.
15. Kamar N, Abravanel F, Lhomme S, Rostaing L, Izopet J. Hepatitis E virus: chronic infection, extra-hepatic manifestations, and treatment. Clin Res Hepatol Gastroenterol 2015; 39: 20–27.
16. Haim-Boukobza S, Ferey MP, Vetillard AL et al. Transfusion-transmitted hepatitis E in a misleading context of autoimmunity and drug-induced toxicity. J Hepatol 2012; 57: 1374–1378.
17. Arankalle VA, Chobe LP. Retrospective analysis of blood transfusion recipients: evidence for post-transfusion hepatitis E. Vox Sang 2000; 79: 72–74.
18. Colson P, Coze C, Gallian P, Henry M, De Micco P, Tamalet C. Transfusion-associated hepatitis E, France. Emerg Infect Dis 2007; 13: 648–649.
19. Hauser L, Roque-Afonso AM, Beyloune A et al. Hepatitis E transmission by transfusion of Intercept blood system-treated plasma. Blood 2014; 123: 796–797.
20. Hewitt PE, Ijaz S, Brailsford SR et al. Hepatitis E virus in blood components: a prevalence and transmission study in southeast England. Lancet 2014; 384: 1766–1773.
21. Huzly D, Umhau M, Bettinger D et al. Transfusion-transmitted hepatitis E in Germany, 2013. Euro Surveill 2014; 19(21): ppi=20812.
22. Boxall E, Herborn A, Kochethu G et al. Transfusion-transmitted hepatitis E in a ‘nonhyperendemic’ country. Transfus Med 2006; 16: 79–83.
23. Matsubayashi K, Kang JH, Sakata H et al. A case of transfusion-transmitted hepatitis E caused by blood from a donor infected with hepatitis E virus via zoonotic food-borne route. Transfusion 2008; 48: 1368–1375.
24. Matsui T, Kang JH, Matsubayashi K et al. Rare case of transfusion-transmitted hepatitis E from the blood of a donor infected with the hepatitis E virus genotype 3 indigenous to Japan: viral dynamics from onset to recovery. Hepatol Res 2015; 45: 698–704.
25. Andonov A, Rock G, Lin L et al. Serological and molecular evidence of a plausible transmission of hepatitis E virus through pooled plasma. Vox Sang 2014; 107: 213–219.
26. Vollmer T, Diekmann J, Johne R, Eberhardt M, Knabbe C, Dreier J. Novel approach for detection of hepatitis E virus infection in German blood donors. J Clin Microbiol 2012; 50: 2708–2713.
27. Baylis SA, Koc O, Nick S, Blumel J. Widespread distribution of hepatitis E virus in plasma fractionation pools. Vox Sang 2012; 102: 182–183.
28. Feray C, Pawlotsky JM, Roque-Afonso AM, Samuel D, Dhumeaux D. Should we screen blood products for hepatitis E virus RNA ? Lancet 2014; 383: 218.
29. Pawlotsky JM. Hepatitis E screening for blood donations: an urgent need? Lancet 2014; 384: 1729–1730.
30. Lefrere JJ, Laperche S, Girot R. Repository of blood samples from recipients of red blood cell transfusions in France. Transfusion 2008; 48: 195.
31. Abravanel F, Lhomme S, Chapuy-Regaud S et al. Hepatitis E virus reinfections in solid-organ-transplant recipients can evolve into chronic infections. J Infect Dis 2014; 209: 1900–1906.
32. Abravanel F, Sandres-Saune K, Lhomme S, Dubois M, Mansuy JM, Izopet J. Genotype 3 diversity and quantification of hepatitis E virus RNA. J Clin Microbiol 2012; 50: 897–902.
33. Legrand-Abravanel F, Mansuy JM, Dubois M et al. Hepatitis E virus genotype 3 diversity, France. Emerg Infect Dis 2009; 15: 110–114.
34. Faber MS, Wenzel JJ, Jilg W, Thamm M, Hohle M, Stark K. Hepatitis E virus seroprevalence among adults, Germany. Emerg Infect Dis 2012; 18: 1654–1657.
35. Chaussade H, Rigaud E, Allix A et al. Hepatitis E virus seroprevalence and risk factors for individuals in working contact with animals. J Clin Virol 2013; 58: 504–508.
36. Pillonel J, Gallian P, Sommen C et al. Assessment of a transfusion emergent risk: the case of HEV. Transfus Clin Biol 2014; 21: 162–166.
37. Kamar N, Garrouste C, Haagsma EB et al. Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants. Gastroenterology 2011; 140: 1481–1489.
38. le Coutre P, Meisel H, Hofmann J et al. Reactivation of hepatitis E infection in a patient with acute lymphoblastic leukaemia after allogeneic stem cell transplantation. Gut 2009; 58: 699–702.
39. Versluis J, Pas SD, Agteresch HJ et al. Hepatitis E virus: an underestimated opportunistic pathogen in recipients of allogeneic hematopoietic stem cell transplantation. Blood 2013; 122: 1079–1086.
40. Baylis SA, Crossan C, Corman VM, Blumel J, Scobie L, Dalton HR. Unusual serological response to hepatitis E virus in plasma donors consistent with re-infection. Vox Sang 2015; 406–409.
41. Zhang J, Li SW, Wu T, Zhao Q, Ng MH, Xia NS. Hepatitis E virus: neutralizing sites, diagnosis, and protective immunity. Rev Med Virol 2012; 22: 339–349.
42. Krain LJ, Nelson KE, Labrique AB. Host immune status and response to hepatitis E virus infection. Clin Microbiol Rev 2014; 27: 139–165.
43. Corwin A, Jarot K, Lubis I et al. Two years’ investigation of epidemic hepatitis E virus transmission in West Kalimantan (Borneo), Indonesia. Trans R Soc Trop Med Hyg 1995; 89: 262–265.
44. Rapicetta M, Kondili LA, Pretolani S et al. Seroprevalence and anti-HEV persistence in the general population of the Republic of San Marino. J Med Virol 1999; 58: 49–53.
45. Mansuy JM, Bendall R, Legrand-Abravanel F et al. Hepatitis E virus antibodies in blood donors, France. Emerg Infect Dis 2011; 17: 2309–2312.